JG
BLU

Jefferies Group’s BELLUS Health Inc. BLU Stock Holding History

Jefferies Group’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-324,476
Closed -$2.61M – 2060
2021
Q4 		$2.61M Buy
324,476
+204,679
+171% +$1.36M 0.02% 701
2021
Q3 		$736K Buy
+119,797
New +$454K 0.01% 1099
2021
Q1 		– Sell
-135,091
Closed -$413K – 2088
2020
Q4 		$413K Buy
+135,091
New +$366K ﹤0.01% 1198

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Jefferies Group's BLU Position: Q1 2022 in Review

Jefferies Group sold out of BELLUS Health Inc. (BLU) in Q1 2022, closing a stake of 324,476 shares — an estimated $2.61M sold.

Jefferies Group first reported a position in BLU in Q4 2020 and held it in 3 quarters. The position peaked at $2.61M in Q4 2021. 77 funds tracked by Wall St. Rank hold BLU as of Q1 2022.

  • Jefferies Group reported no remaining BELLUS Health Inc. position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 324,476 BELLUS Health Inc. shares in Q1 2022, an estimated $2.61M.
  • Jefferies Group first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 3 quarters.
  • Jefferies Group's BELLUS Health Inc. position peaked at $2.61M in Q4 2021.
  • 77 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.